Kivikko M - Search Results

1

Effect of baseline characteristics on mortality in the SURVIVE trial on the effect of levosimendan vs dobutamine in acute heart failure: Sub-analysis of the Finnish patients.

Kivikko M, Pollesello P, Tarvasmäki T, Sarapohja T, Nieminen MS, Harjola VP. Kivikko M, et al. Int J Cardiol. 2016 Jul 15;215:26-31. doi: 10.1016/j.ijcard.2016.04.064. Epub 2016 Apr 14. Int J Cardiol. 2016. PMID: 27107540 Free article. Clinical Trial.

2

Pharmacodynamics and safety of a new calcium sensitizer, levosimendan, and its metabolites during an extended infusion in patients with severe heart failure.

Kivikko M, Antila S, Eha J, Lehtonen L, Pentikäinen PJ. Kivikko M, et al. J Clin Pharmacol. 2002 Jan;42(1):43-51. doi: 10.1177/0091270002042001005. J Clin Pharmacol. 2002. PMID: 11808823 Clinical Trial.

3

Pharmacokinetics of levosimendan and its metabolites during and after a 24-hour continuous infusion in patients with severe heart failure.

Kivikko M, Antila S, Eha J, Lehtonen L, Pentikäinen PJ. Kivikko M, et al. Int J Clin Pharmacol Ther. 2002 Oct;40(10):465-71. doi: 10.5414/cpp40465. Int J Clin Pharmacol Ther. 2002. PMID: 12395979 Clinical Trial.

4

Sustained hemodynamic effects of intravenous levosimendan.

Kivikko M, Lehtonen L, Colucci WS. Kivikko M, et al. Circulation. 2003 Jan 7;107(1):81-6. doi: 10.1161/01.cir.0000043245.00859.11. Circulation. 2003. PMID: 12515747 Clinical Trial.

5

Pharmacokinetics of levosimendan and its circulating metabolites in patients with heart failure after an extended continuous infusion of levosimendan.

Antila S, Kivikko M, Lehtonen L, Eha J, Heikkilä A, Pohjanjousi P, Pentikäinen PJ. Antila S, et al. Among authors: kivikko m. Br J Clin Pharmacol. 2004 Apr;57(4):412-5. doi: 10.1111/j.1365-2125.2003.02043.x. Br J Clin Pharmacol. 2004. PMID: 15025738 Free PMC article. Clinical Trial.

6

Levosimendan: a new inodilatory drug for the treatment of decompensated heart failure.

Kivikko M, Lehtonen L. Kivikko M, et al. Curr Pharm Des. 2005;11(4):435-55. doi: 10.2174/1381612053382043. Curr Pharm Des. 2005. PMID: 15725064 Review.

7

Duration of the haemodynamic action of a 24-h infusion of levosimendan in patients with congestive heart failure.

Lilleberg J, Laine M, Palkama T, Kivikko M, Pohjanjousi P, Kupari M. Lilleberg J, et al. Among authors: kivikko m. Eur J Heart Fail. 2007 Jan;9(1):75-82. doi: 10.1016/j.ejheart.2006.04.012. Epub 2006 Jul 7. Eur J Heart Fail. 2007. PMID: 16829185 Free article. Clinical Trial.

8

Effect of severe renal failure and haemodialysis on the pharmacokinetics of levosimendan and its metabolites.

Puttonen J, Kantele S, Kivikko M, Häkkinen S, Harjola VP, Koskinen P, Pentikäinen PJ. Puttonen J, et al. Among authors: kivikko m. Clin Pharmacokinet. 2007;46(3):235-46. doi: 10.2165/00003088-200746030-00004. Clin Pharmacokinet. 2007. PMID: 17328582 Clinical Trial.

9

Levosimendan vs dobutamine for patients with acute decompensated heart failure: the SURVIVE Randomized Trial.

Mebazaa A, Nieminen MS, Packer M, Cohen-Solal A, Kleber FX, Pocock SJ, Thakkar R, Padley RJ, Põder P, Kivikko M; SURVIVE Investigators. Mebazaa A, et al. Among authors: kivikko m. JAMA. 2007 May 2;297(17):1883-91. doi: 10.1001/jama.297.17.1883. JAMA. 2007. PMID: 17473298 Clinical Trial.

10

Oral levosimendan in patients with severe chronic heart failure --the PERSIST study.

Nieminen MS, Cleland JG, Eha J, Belenkov Y, Kivikko M, Põder P, Sarapohja T. Nieminen MS, et al. Among authors: kivikko m. Eur J Heart Fail. 2008 Dec;10(12):1246-54. doi: 10.1016/j.ejheart.2008.09.006. Epub 2008 Oct 21. Eur J Heart Fail. 2008. PMID: 18945637 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

44 results

Search Page

Filters